Inspire Medical Systems, Inc.
Inspire Medical Systems Reports Strong Q4 and FY 2023 Results with Revenue Growth
Summary
Inspire Medical Systems, Inc. announced its financial results for Q4 and the full year of 2023, showing a 40% increase in Q4 revenue year-over-year, reaching $192.5 million. Full-year 2023 revenue was $624.8 million, a 53% increase over 2022. The company also reported net income of $14.8 million for Q4 2023, with a gross margin of 85.4%. The company expects Q4 2024 revenue to be in the range of $775 million to $785 million.
Profitelligence Alerts
Get alerts for INSP
Be first to know when Inspire Medical Systems, Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. is a pioneering company focused on developing and commercializing innovative medical technology designed to treat obstructive sleep apnea (OSA). The company's flagship product, the Inspire therapy, is an implantable neurostimulation device that provides a unique and effective solution for patients who are unable to utilize traditional continuous positive airway pressure (CPAP) devices. Inspire Medical Systems significantly impacts the healthcare sector by offering a less invasive, patient-friendly alternative to surgical treatments for OSA, improving quality of life for those affected by sleep disorders. Headquartered in Minnesota, Inspire Medical Systems continues to expand its presence within the medical device market, collaborating closely with hospitals and medical professionals to enhance sleep health management globally. This company's contributions underscore a growing focus on personalized and technologically advanced approaches to medical challenges, marking its importance in the evolving landscape of healthcare solutions.
Official SEC Documents
Advertisement